Antongiulio Faggiano

Pubblicazioni

Titolo Pubblicato in Anno
Somatostatin analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life ONCOTARGET 2016
Benign thyroid nodules with RAS mutation grow faster CLINICAL ENDOCRINOLOGY 2016
Low glycaemic diet and metformin therapy. a new approach in male subjects with acne resistant to common treatments CLINICAL AND EXPERIMENTAL DERMATOLOGY 2016
Rare diseases in clinical endocrinology: a taxonomic classification system JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2015
Italian Society of Endocrinology Consensus Statement: Definition, evaluation and management of patients with mild primary hyperparathyroidism JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2015
Pituitary function and morphology in Fabry disease ENDOCRINE 2015
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib ENDOCRINE 2015
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication ENDOCRINE 2015
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge ENDOCRINE 2015
The evolving field of kinase inhibitors in thyroid cancer CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2015
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 2015
Letter. the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 score ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2015
Complete clinical and biochemical control with cabergoline and octreotide in a patient with ectopic ACTH syndrome before surgery JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2015
Epidemiology of Neuroendocrine Tumors Neuroendocrine Tumors. A Multidisciplinary Approach 2015
Erratum to. GLP-1. benefits beyond pancreas JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2015

ERC

  • LS2_1
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_12
  • LS7_4
  • LS7_8
  • LS7_10
  • LS7_14

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

La principale area di ricerca sono è l'endocrinologia oncologica con numerose pubblicazioni e progetti clinici e traslazionali sulle neoplasie neuroendocrine, le neoplasie tiroidee, l'iperparatiroidismo, i tumori ipofisari, i feocromocitomi e paragangliomi, le sindromi neoplastiche genetiche multiendocrine. In tale ambito l'interesse di ricerca va dagli studi epidemiologici e di valutazione di fattori prognostici clinici e molecolari, studi sul ruolo della sindrome metabolica, della nutrizione e dei fatoori ambientali sulle neoplasie endocrine e neuroendocrine, studi genetici (ricerca nuove mutazioni, VUS, screening genetico, analisi NGS), studi diagnostici sulla diagnosi biochimica e ormonale e la diagnosi di imaging, studi terapeutici sull'efficacia e tossicità di farmaci biologici come analoghi della somatostatina, dopamino-agonisti, inibitori di mTOR, inibitori tirosino-chinasici. Più di recente interesse per l'andrologia, i tumori testicolari e le malattie genetiche della sfera andrologica

Keywords

neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma